首页> 外文期刊>CNS neuroscience & therapeutics >Opportunities and Challenges: Stem Cell-Based Therapy for the Treatment of Ischemic Stroke
【24h】

Opportunities and Challenges: Stem Cell-Based Therapy for the Treatment of Ischemic Stroke

机译:机遇与挑战:基于干细胞的缺血性卒中治疗

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Stem cell-based therapy for ischemic stroke has been widely explored in animal models and provides strong evidence of benefits. In this review, we summarize the types of stem cells, various delivery routes, and tracking tools for stem cell therapy of ischemic stroke. MSCs, EPCs, and NSCs are the most explored cell types for ischemic stroke treatment. Although the mechanisms of stem cell-based therapies are not fully understood, the most possible functions of the transplanted cells are releasing growth factors and regulating microenvironment through paracrine mechanism. Clinical application of stem cell-based therapy is still in its infancy. The next decade of stem cell research in stroke field needs to focus on combining different stem cells and different imaging modalities to fully explore the potential of this therapeutic avenue: from bench to bedside and vice versa.
机译:在动物模型中已经广泛探索了基于干细胞的缺血性中风疗法,并提供了有益的有力证据。在这篇综述中,我们总结了干细胞的类型,各种递送途径以及缺血性中风干细胞治疗的追踪工具。 MSC,EPC和NSC是用于缺血性中风治疗的研究最多的细胞类型。尽管尚未完全了解基于干细胞的疗法的机制,但移植细胞最可能的功能是释放生长因子并通过旁分泌机制调节微环境。基于干细胞疗法的临床应用仍处于起步阶段。脑卒中领域下一个干细胞研究的下一个十年需要集中于结合不同的干细胞和不同的成像方式,以充分探索这种治疗途径的潜力:从长凳到床头,反之亦然。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号